AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

Delisting riskPopularity #3,931

HYPR · NASDAQ · Medical - Devices

Hyperfine (HYPR)

Makes and supports Swoop, a portable ultra-low-field brain-MRI system.

$0.8139

vs last close+0.03 (+4.20%)

MedtechWOMEN Names Hyperfine CEO Maria Sainz Winner of 2026 Ferolyn Powell Leadership Award
Business WireSep 16
Hyperfine Builds Momentum in Year One of Neurology Office Launch with NEURO PMR Publication and More Than 3,000 Scans
GuruFocusAug 26Product
Hyperfine Builds Momentum in Year One of Neurology Office Launch with NEURO PMR Publication and More Than 3,000 Scans
Business WireAug 26Product
Hyperfine Announces FDA Clearance of the Next Optive AI™ Software, Further Enhancing Image Quality, Clinical Utility, and Ease of Use of the Swoop® System Across Care Settings
GuruFocusAug 20Clinical
Hyperfine Announces FDA Clearance of the Next Optive AI™ Software, Further Enhancing Image Quality, Clinical Utility, and Ease of Use of the Swoop® System Across Care Settings
Business WireAug 20Clinical
Hyperfine, Inc. (HYPR) Q2 2026 Earnings Call Transcript
Seeking AlphaAug 7
Hyperfine Q2 Earnings Call Highlights
MarketBeatAug 6
Hyperfine, Inc. Reports Second Quarter 2026 Financial Results
Business WireAug 6
Hyperfine Announces the Release of Multiple Peer-Reviewed Publications, Expanding Clinical Evidence for the Swoop® System Across a Growing Number of Sites of Care
Business WireJul 30
Hyperfine, Inc. to Announce Second Quarter 2026 Financial Results on August 6, 2026
Business WireJul 23
Hyperfine Announces European Launch of Next-Generation Swoop® System
Business WireJul 1
Hyperfine Forms Global Neurosurgery Advisory Council to Support Expansion of Portable MRI in Neurosurgical Care
Business WireJun 22
Hyperfine Swoop® System Scan Volume in the United States Hits Record Milestones Across Multiple Sites of Care
GuruFocusJun 18
Hyperfine Swoop® System Scan Volume in the United States Hits Record Milestones Across Multiple Sites of Care
Business WireJun 18
Hyperfine, Inc. (HYPR) Presents at Jefferies Global Healthcare Conference 2026 Prepared Remarks Transcript
Seeking AlphaJun 5
Hyperfine to Join Russell 2000® and Russell 3000® Indexes
GuruFocusMay 26
Hyperfine Announces Presentation of Results from the PRIME Study Showing Portable MRI Substantially Reduces Time to Imaging in Emergency Departments
Business WireMay 22
Hyperfine, Inc. (HYPR) Reports Q1 Loss, Beats Revenue Estimates
Zacks Investment ResearchMay 12
Hyperfine, Inc. Reports First Quarter 2026 Financial Results
Business WireMay 12
Hyperfine, Inc. to Participate in Upcoming 2026 Jefferies Global Healthcare Conference
Business WireMay 6